LMDXF LumiraDx
- 0.022
- +0.003+18.78%
LumiraDx News
News On LumiraDx Ltd. (LMDX) Now Under LMDXF
News On LumiraDx Ltd. (LMDX) Now Under LMDXF
U.S. Shares Higher at Close of Trade; Dow Jones Industrial Average up 0.58%
Top Midday Decliners
Solo Brands (DTC) said it appointed Christopher T. Metz as its new President and Chief Executive Officer, starting from Jan. 15, replacing John Merris. Shares slumped more than 36%, with intraday trad
US Stocks Mixed; Nasdaq Jumps Over 100 Points
U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining around 100 points on Monday. Following the market opening Monday, the Dow traded down 0.45% to 37,296.85 while the NASDAQ rose
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersHarpoon Therapeutics (NASDAQ:HARP) stock increased by 110.9% to $22.25 during Monday's pre-market session. The company's market cap stands at $376.7 million. Ambrx Biopharma (NASDAQ:AMAM) stock
LumiraDx Announces Its Securities Will Be Suspended From Trading On Nasdaq At The Open Of Business On January 9th
LumiraDx Limited (NASDAQ:LMDX)(the "Company") today announced that it has received notification from The Nasdaq Stock Market LLC ("Nasdaq") that its securities will be suspended from trading at the op
LumiraDx Announces Its Securities Will Be Suspended From Trading on Nasdaq at the Open of Business on January 9th
LONDON, Jan. 05, 2024 (GLOBE NEWSWIRE) -- LumiraDx Limited (NASDAQ:LMDX)(the "Company") today announced that it has received notification from The Nasdaq Stock Market LLC ("Nasdaq") that its securities will be
Dow Down 100 Points; US Manufacturing PMI Falls In December
U.S. stocks traded lower this morning, with the $Dow Jones Industrial Average(.DJI.US)$ index falling more than 100 points on Tuesday.Following the market opening Tuesday, the Dow traded down 0.28% to
Roche (RHHBY) to Acquire LumiraDx's Point of Care Technology
Wall Street Set to Open 2024 Lower Amid Rise in Oil Prices, Ahead of Manufacturing, Construction Data
US stocks looked set to open lower in the first trading session of 2024 as oil prices climbed and investors looked ahead to monthly manufacturing and construction spending data. Dow Jones Industrial A
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersLongboard Pharmaceuticals (NASDAQ:LBPH) shares increased by 157.0% to $15.5 during Tuesday's pre-market session. The market value of their outstanding shares is at $369.7 million. Cue Health (N
Roche Agrees To Purchase Part Of COVID-19 Test Player LumiraDx Diagnostics Platform For $295M
Friday, LumiraDx Limited (NASDAQ:LMDX) appointed joint administrators for two subsidiaries. The administrators signed a definitive agreement to sell certain companies of LumiraDx related to LumiraDx's
LumiraDx Falls on Agreement With Roche to Sell Assets
LumiraDx, Sacks Parente Golf And 3 Stocks To Watch Heading Into Tuesday
With U.S. stock futures trading mixed this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: Sacks Parente Golf, Inc. (NASDAQ:SPGC) announced the resignation o
Roche to Buy LumiraDx's Point of Care Technology Assets in Over $295 Million Deal
Roche (ROG.SW, RO.SW) signed a definitive agreement to buy a portion of the Nasdaq-listed LumiraDx group, comprising a range of immunoassay and clinical chemistry tests, for $295 million, according to a filing on Dec. 29, 2023.
12 Health Care Stocks Moving In Monday's After-Market Session
GainersNGM Biopharmaceuticals (NASDAQ:NGM) shares moved upwards by 43.2% to $1.23 during Monday's after-market session. The company's market cap stands at $101.7 million. Cue Health (NASDAQ:HLTH) shar
Press Release: LumiraDx Announces Agreement to Sell Its Cutting Edge Point of Care Technology Platform to Roche
LumiraDx Limited (Nasdaq: LMDX) (the "Company"), a next generation point of care diagnostics company, announced today the appointment of joint administrators for two of its subsidiaries.
LumiraDx Shares Halted, News Pending
LumiraDx Shares Halted, News Pending
Express News | Trading Halt: Halted at 4:10:00 P.m. ET - Trading Halt: Halt News Pending
LumiraDx Ltd 13D/Amended Filing Shows Willard L. Umphrey Reports 10.31% Stake In The Co As Of Dec 22
LumiraDx Ltd 13D/Amended Filing Shows Willard L. Umphrey Reports 10.31% Stake In The Co As Of Dec 22
Analysis
Price Target
No Data
